Target type | Target name | Sequence | Foundations used in replicates |
---|---|---|---|
Spot-Tag∗ (peptide target) | Spot-Tag.01 | (N-terminus)-PDRVRAVSHWSSGGG-Cys (C-terminus)-3′ATCCCTTCTCTTCCTGTAT ACTAATAGGTGCACGTAGATTC/5Phos/ |
Fd31, Fd19, Fd20, Fd27, Fd28, Fd29 |
Bradykinin∗ (peptide target control for non-specific binding) |
Brady.01 | (N-terminus)-RPPGFSPFR-Cys (C-terminus)-3′ATCCCTTCTCTTCCTGTAT ACTAATAGGTGCACGTAGATTC/5Phos/ |
Fd12, Fd13, Fd14 |
DNA∗∗ (null control) |
CLR.Null.Block | CTTAGATGCACGTGGATAAT | Fd24, Fd25, Fd26 |
DNA∗∗ (null control) |
5′Phos.01 | /5Phos/CTTAGATGCACGTGGATA | Fd7, Fd8, Fd11 |
DNA∗∗ (positive control) |
DNA Target 6.01 | /5Phos/CTTAGATGCACGTGGATAATCATA TGTCCTTCTCTTCCCTAATGAAGTAC TAA CCTGA |
Fd21, Fd22, Fd23 |
DNA∗∗ (positive control) |
DNA Target 4.01 | /5Phos/CTTAGATGCACGTGGATAATCATA TGTCCTTCTCTTCCCTAATAGGATTCC | Fd15, Fd16, Fd17 |
∗The C-terminal of the peptide targets is directly conjugated to the 3′ end of one DNA tail via a cysteine.
∗∗Binding sequences and DNA tails of DNA targets are continuous oligos rather than conjugated through another chemical conjugation method.